Skip to content

Clinical trials

Phase 2/3 Arterial Occlusive Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arterial Occlusive Diseases Phase: Phase 2/3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20042
20071
20111
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital Tuebingen2
Anesiva, Inc.1
Brigham and Women's Hospital1
Franziskus-Krankenhaus1
Karolinska Institutet1
University of Patras1
Xiang Luo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arterial Occlusive Diseases8
Peripheral Vascular Diseases4
Ischemia2
Peripheral Arterial Disease2
Atherosclerosis1
Diabetes Mellitus1
Diabetic Foot1
Gangrene1
Graft Occlusion, Vascular1
Hyperplasia1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.